HYTACAND

Swiss trademark · 438629 · Word mark · Deleted

Register entry

Registration number
438629
Application number
06117/1996
Status
Deleted
Type
Word mark
Filed
Aug 23, 1996
Registered
Mar 25, 1997
Published
Apr 15, 1997
Deleted
Mar 27, 2017
Reason
Not renewed
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate für die Behandlung von kardiovaskulären Krankheiten.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 27, 2017

    Deleted, not renewed

    Published in Swissreg on 27.03.2017

  2. Apr 16, 2014

    Agent’s address changed

    Representative
    A.W. Metz & Co. AG, Hottingerstrasse 14, 8024 Zürich → A.W. Metz & Co. AG, Kreuzbühlstrasse 8, 8008 Zürich

    Published in Swissreg on 16.04.2014

  3. May 29, 2006

    Renewed

    Published in the SOGC no. 102 of 29.05.2006

  4. Apr 24, 2001

    Holder’s address changed

    Owner
    Astra Aktiebolag, Västra Mälarehamnen 9, S-151 85 Södertälje, Sweden → AstraZeneca AB, 151 85 Södertälje, Sweden

    Published in the SOGC no. 78 of 24.04.2001

  5. Apr 15, 1997

    Registered

    Published in the SOGC no. 70 of 15.04.1997

Parties

Holder

AstraZeneca AB

151 85 Södertälje, SE

Agent

A. W. Metz & Co. AG in Liquidation

A.W. Metz & Co. AG

Kreuzbühlstrasse 8, 8008 Zürich

In liquidation

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.